Literature DB >> 23242822

Rapid deamidation of recombinant protective antigen when adsorbed on aluminum hydroxide gel correlates with reduced potency of vaccine.

Ajit Joseph M D'Souza1, Kevin D Mar, Joanne Huang, Sumit Majumdar, Brandi M Ford, Beverly Dyas, Robert G Ulrich, Vincent J Sullivan.   

Abstract

Deamidation of the recombinant protective antigen (rPA) correlates with decreased effectiveness of the vaccine in protecting against infection by Bacillus anthracis. We present data demonstrating dramatic deamidation of amino acid positions 713 and 719 of rPA adsorbed onto aluminum hydroxide gel, an adjuvant, relative to rPA stored in solution without adjuvant. Although deamidation did not impact total levels of rPA-specific antibodies in a mouse model, it did correlate with a decrease in toxin-neutralizing antibodies. On the basis of these data, we hypothesize that interactions of rPA with aluminum hydroxide gel are destabilizing and are the direct cause of reduced vaccine efficacy.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23242822     DOI: 10.1002/jps.23422

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  13 in total

1.  Mechanistic Analysis of the Effect of Deamidation on the Immunogenicity of Anthrax Protective Antigen.

Authors:  Anita Verma; Miriam M Ngundi; Drusilla L Burns
Journal:  Clin Vaccine Immunol       Date:  2016-05-06

2.  Glassy-state stabilization of a dominant negative inhibitor anthrax vaccine containing aluminum hydroxide and glycopyranoside lipid A adjuvants.

Authors:  Kimberly J Hassett; David J Vance; Nishant K Jain; Neha Sahni; Lilia A Rabia; Megan C Cousins; Sangeeta Joshi; David B Volkin; C Russell Middaugh; Nicholas J Mantis; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2015-01-11       Impact factor: 3.534

3.  Two approaches for the stabilization of Bacillus anthracis recombinant protective antigen.

Authors:  Ekaterina M Ryabchevskaya; Ekaterina A Evtushenko; Dmitry L Granovskiy; Peter A Ivanov; Joseph G Atabekov; Olga A Kondakova; Nikolai A Nikitin; Olga V Karpova
Journal:  Hum Vaccin Immunother       Date:  2020-07-02       Impact factor: 3.452

4.  Combination of two candidate subunit vaccine antigens elicits protective immunity to ricin and anthrax toxin in mice.

Authors:  David J Vance; Yinghui Rong; Robert N Brey; Nicholas J Mantis
Journal:  Vaccine       Date:  2014-12-02       Impact factor: 3.641

5.  Engineering the hydroxyl content on aluminum oxyhydroxide nanorod for elucidating the antigen adsorption behavior.

Authors:  Ge Yu; Zhihui Liang; Zilan Yu; Min Li; Wenqi Yang; Yawei Zhang; Yuhang Zhao; Cheng Yang; Changying Xue; Li Shi; Bingbing Sun
Journal:  NPJ Vaccines       Date:  2022-06-23       Impact factor: 9.399

6.  Biophysical characterization and immunization studies of dominant negative inhibitor (DNI), a candidate anthrax toxin subunit vaccine.

Authors:  Vidyashankara Iyer; Lei Hu; Carole E Schanté; David Vance; Chrystal Chadwick; Nishant Kumar Jain; Robert N Brey; Sangeeta B Joshi; David B Volkin; Kiran K Andra; James G Bann; Nicholas J Mantis; C Russell Middaugh
Journal:  Hum Vaccin Immunother       Date:  2013-08-07       Impact factor: 3.452

7.  A Bivalent Anthrax-Plague Vaccine That Can Protect against Two Tier-1 Bioterror Pathogens, Bacillus anthracis and Yersinia pestis.

Authors:  Pan Tao; Marthandan Mahalingam; Jingen Zhu; Mahtab Moayeri; Michelle L Kirtley; Eric C Fitts; Jourdan A Andersson; William S Lawrence; Stephen H Leppla; Ashok K Chopra; Venigalla B Rao
Journal:  Front Immunol       Date:  2017-06-26       Impact factor: 7.561

8.  Structural Characterization and Physicochemical Stability Profile of a Double Mutant Heat Labile Toxin Protein Based Adjuvant.

Authors:  Vishal M Toprani; John M Hickey; Neha Sahni; Ronald T Toth; George A Robertson; C Russell Middaugh; Sangeeta B Joshi; David B Volkin
Journal:  J Pharm Sci       Date:  2017-08-02       Impact factor: 3.534

Review 9.  Current Status and Trends in Prophylaxis and Management of Anthrax Disease.

Authors:  Vladimir Savransky; Boris Ionin; Joshua Reece
Journal:  Pathogens       Date:  2020-05-12

10.  A Bacteriophage T4 Nanoparticle-Based Dual Vaccine against Anthrax and Plague.

Authors:  Pan Tao; Marthandan Mahalingam; Jingen Zhu; Mahtab Moayeri; Jian Sha; William S Lawrence; Stephen H Leppla; Ashok K Chopra; Venigalla B Rao
Journal:  mBio       Date:  2018-10-16       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.